Biotech

All Articles

Takeda faucets brand-new head people oncology company-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of significant management hirings, firings a...

Vertex, hammered through AATD once again, goes down 2 properties on discard heap

.Tip's attempt to handle a rare genetic ailment has actually struck one more trouble. The biotech th...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of team

.Vir Medical's second-quarter revenues report had not been short of large updates. The business invi...

Galapagos stops briefly CAR-T cell treatment trial over Parkinsonism scenario

.Galapagos has actually stopped application in a test of a BCMA-directed CAR-T tissue treatment, pus...

James Wilson leaving Penn to launch pair of brand new biotechs

.After much more than three decades, gene treatment trendsetter James Wilson M.D., Ph.D., is leaving...

3 biotechs try to beat the summer months warmth by dropping staff

.As biotechs try to switch a new page in August, at least three companies have shed staff in attempt...

venBio elevates $528M for fifth lifestyle sciences VC fund

.Expert financial backing firm venBio has actually raised one more half a billion dollars to buy bio...

Otsuka pays out $800M for Jnana and its clinical-stage PKU drug

.Otsuka Drug has actually grabbed Boston-based Jnana Therapeutics for $800 thousand so the Japanese ...

FibroGen lays off 75% of US workers as asset flunks 2 more trials

.FibroGen is actually radically reorganizing its own company, giving up 75% of its U.S. workers and ...

Tracon wane weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has chosen to wind down operations weeks after an injectable immune system c...